Global epidemiology of haemoglobin disorders and derived service indicators
Bernadette Modell, Matthew Darlison
Volume 86, Number 6, June 2008, 480-487
Table 3. Estimated reach of treatment for β thalassaemia in each WHO regiona
| WHO region | Estimated annualbirths |
Transfusion |
No. of known patients | Adequate iron chelation |
Inadequate or no iron chelation |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Transfusion-dependent | Annual no. starting transfusion | % of transfusion-dependent patients transfused | Annualdeaths because not transfused | % with chelation | No. with chelation | No. of patients | Annual deaths due to iron overload | ||||||
| African | 1 386 | 1 278 | 35 | 2.7 | 1 243 | – | – | – | – | – | ||||
| American | 341 | 255 | 134 | 52.4 | 121 | 2 750 | 58 | 1 604 | 1 146 | 57 | ||||
| Eastern Mediterranean | 9 914 | 9 053 | 1 610 | 17.8 | 7 443 | 39 700 | 27 | 10 818 | 28 882 | 1 444 | ||||
| European | 1 019 | 920 | 140 | 15.5 | 780 | 16 230 | 91 | 14 754 | 1 476 | 74 | ||||
| South-east Asian | 20 420 | 9 983 | 962 | 9.6 | 9 021 | 35 500 | 19 | 6 621 | 28 879 | 1 444 | ||||
| WesternPacific | 7 538 | 4 022 | 108 | 2.7 | 3 914 | 3 450 | 44 | 1 504 | 1 946 | 97 | ||||
a All figures are minimum estimates.